Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients

May 12, 2024 updated by: Reham Zakaria Mohamed Ahmed, Zagazig University

Surgery Versus Laser Ablation of Anal Diseases in Inflammatory Bowel Disease Patients

This is a randomized comparative clinical trial carried out to compare between laser ablation and surgery in treating anal diseases in inflammatory bowel diseases patients and find out if one is superior to the other.

Inflammatory bowel diseases patients with anal problems were divided into 2 groups, one group had traditional surgery and the other had laser ablation for anal diseases and results were compared between the 2 groups.

Study Overview

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zagazig, Egypt, 44519
        • Zagazig University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with history of inflammatory bowel disease ( non specific colitis, crohn's disease, ulcerative colitis).
  • Patients who accidently discovered to have inflammatory bowel disease.
  • Age group between 18 to 60 years old

Exclusion Criteria:

  • Informed consent refusal.
  • Proved malignancy in inflammatory bowel disease patients
  • Patients less than 18 years old or more than 60 years old
  • Contraindications to general and spinal anesthesia
  • other types of colitis as ischemic colitis, pseudo-membranous colitis, infective colitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: laser
laser ablation of anal diseases in inflammatory bowel patients
treatment of anal diseases in inflammatory bowel patients
laser
Sham Comparator: traditional surgery
traditional surgery for anal diseases in inflammatory bowel patients
treatment of anal diseases in inflammatory bowel patients
traditional surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operation time
Time Frame: Intraoperative (from skin incision to wound dressing.)
operation time in minutes was studied between the 2 groups
Intraoperative (from skin incision to wound dressing.)
operative bleeding
Time Frame: Intraoperative to 2 weeks after operation.
bleeding in cc was calculated between the 2 groups
Intraoperative to 2 weeks after operation.
post operative anal discharge
Time Frame: from incision to 2 weeks after operation.
presence of post operative anal discharge was detected in the 2 groups
from incision to 2 weeks after operation.
pain score with visual analogue scale
Time Frame: from the 1st day to 2 weeks postoperatively
pain score with visual analogue scale was studied between the 2 groups,minimum score is 0 which means painless and maximum score is 10 which means very painful
from the 1st day to 2 weeks postoperatively
Healing time
Time Frame: healing time was studies from the 1st day to 3 months after operation
time for complete healing after operation was studied between the 2 groups
healing time was studies from the 1st day to 3 months after operation
Return to work
Time Frame: Return to work was assessed from one day to 2 months after surgery
Return to work after operation was studied between the 2 groups
Return to work was assessed from one day to 2 months after surgery
patient satisfaction score
Time Frame: from one day to 3 months after operation
patient satisfaction score among patients in the 2 groups was studied using customer satisfaction score, minimum score is 1 means very dissatisfied and maximum score is 10 means very satisfied
from one day to 3 months after operation
Recurrence
Time Frame: detection of recurrence from 3 to 6 months after operation
recurrence between 2 groups was assessed
detection of recurrence from 3 to 6 months after operation
Fistula occurence
Time Frame: from 2 weeks to 2 months after operation
fistula occurence studied between the 2 groups
from 2 weeks to 2 months after operation
Stenosis
Time Frame: stenosis was detected from wound healing to 6 months later
post operative stenosis between the 2 groups was studied
stenosis was detected from wound healing to 6 months later
Discharge from hospital
Time Frame: from one day post operative to one week
hospital stay studied between the 2 groups
from one day post operative to one week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
age
Time Frame: age of participants was recorded for one year duration of the study
age in the 2 groups was studied
age of participants was recorded for one year duration of the study
sex
Time Frame: sex of participants was recorded for one year duration of the study
sex was studied in the 2 groups
sex of participants was recorded for one year duration of the study
specific disease
Time Frame: diagnosis of diseases known 2 days before surgery from history
diagnosis of crohn's disease, ulcerative colitis, non specific colitis by colonoscopy and biopsy was done in the 2 groups
diagnosis of diseases known 2 days before surgery from history

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Reham Zakaria, PhD, Faculty of Medicine Zagazig University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2023

Primary Completion (Actual)

April 5, 2024

Study Completion (Actual)

April 5, 2024

Study Registration Dates

First Submitted

December 27, 2023

First Submitted That Met QC Criteria

January 19, 2024

First Posted (Actual)

January 22, 2024

Study Record Updates

Last Update Posted (Actual)

May 14, 2024

Last Update Submitted That Met QC Criteria

May 12, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Bowel Diseases

Clinical Trials on treatment of anal diseases in inflammatory bowel patients

Subscribe